Stada Expands Portfolio In US And Nordics As First-Half Sales Rise
Executive Summary
Stada reported Branded Products sales up 9% in the first half as it secured two additions to its portfolio, with a US dietary supplement brand and Nordic herbal analgesic.
You may also be interested in...
EU Business News: Biofarm Wants Double-Digit Growth, Medis Strikes Salix Deal, Theramex Gets New Owners
A round-up of the latest European consumer health business news: Romania's Biofarm targets double-digit growth in 2022; Slovenia's Medis strikes deal with Salix for new product launch; and the UK's Theramex acquired by Carlyle and PAI Partners.
Stada's Sales Grow Double Digits In 2021
Stada strengthened its position as Europe's fourth-largest OTC player in 2021 as sales at its Consumer Healthcare business jumped by 15%.
EU Business News: Nestlé Cuts L'Oréal Stake, Stada Sets Up In Sweden
The latest news from Europe's health, beauty and wellness markets: Nestlé is reducing its stake in L'Oréal to fund an expanded share buyback program; and Stada has opened in office in Sweden to manage the distribution and marketing of a portfolio of well-established Sanofi brands.